Trial Profile
An observational trial to assess tocilizumab in patients with rheumatoid arthritis who received tocilizumab, or anti-tumour necrosis factor alpha therapy, as their first biologic therapy, versus those who received tocilizumab as either their first or subsequent biologic therapy
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 27 Jul 2015
Price :
$35
*
At a glance
- Drugs Tocilizumab (Primary) ; Adalimumab; Certolizumab pegol; Etanercept; Infliximab
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- 27 Jul 2015 New trial record
- 10 Jun 2015 Results presented at the 16th Annual Congress of the European League Against Rheumatism.